Characterization of a simple and homogeneous irradiation device based on light-emitting diodes: A possible low-cost supplement to conventional light sources for photodynamic treatment

Medical Laser Application

Volumn 21, Issue 4, 2006, Pages 277-283

  Pieslinger, Anja ^a   Plaetzer, Kristjan ^a   Oberdanner, Christian Benno ^a   Berlanda, Juergen ^a   Mair, Heidemarie ^a   Krammer, Barbara ^a   Kiesslich, Tobias ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Hypericin; Illumination device; LED array; mTHPC; Photodynamic treatment; Photofrin

Indexed keywords

COST EFFECTIVENESS; ELECTRIC CURRENTS; IRRADIATION; PHOTODYNAMIC THERAPY; TUMORS;

HYPERICIN; ILLUMINATION DEVICE; LED ARRAY; META-TETRA (HYDROXYPHENYL) CHLORIN (MTHPC); PHOTODYNAMIC TREATMENT(PDT); PHOTOFRIN;

LIGHT EMITTING DIODES;

HYPERICIN; PHOTOFRIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEVICE; HUMAN; HUMAN CELL; ILLUMINATION; IRRADIATION; IRRADIATION DEVICE; LIGHT EMITTING DIODE; PHOTODYNAMIC THERAPY; RADIOSENSITIVITY; REPRODUCIBILITY; SURVIVAL; TEMPERATURE;

EID: 33750296488     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mla.2006.07.004     Document Type: Article

References (28)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. J Natl Cancer Inst 90 12 (1998) 889-905
2. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 55 1 (1992) 145-157
3. Allison R.R., Downie G.H., Cuenca R., Hu X., Childs C.J.H., and Sibata C.H. Photosensitizers in clinical PDT. Photodiagnosis Photodyn Therapy 1 1 (2004) 27-42
4. Sharman W.M., Allen C.M., and van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 4 11 (1999) 507-517
5. Sibata C.H., Colussi V.C., Oleinick N.L., and Kinsella T.J. Photodynamic therapy in oncology. Expert Opin Pharmacother 2 6 (2001) 917-927
6. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5 8 (2004) 497-508
7. Dougherty T.J. An update on photodynamic therapy applications. J Clin Laser Med Surg 20 1 (2002) 3-7
8. Adili F., Statius van Eps R.G., and LaMuraglia G.M. Significance of dosimetry in photodynamic therapy of injured arteries: classification of biological responses. Photochem Photobiol 70 4 (1999) 663-668
9. D'Hallewin M.A., and Baert L. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology 45 5 (1995) 763-767
10. Tan I.B., Oppelaar H., Ruevekamp M.C., Veenhuizen R.B., Timmers A., and Stewart F.A. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck 21 5 (1999) 434-441
11. Wang K.K., and Nijhawan P.K. Complications of photodynamic therapy in gastrointestinal disease. Gastrointest Endosc Clin N Am 10 3 (2000) 487-495
12. Juzeniene A., Juzenas P., Ma L.W., Iani V., and Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 19 3 (2004) 139-149
13. Brancaleon L., and Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17 3 (2002) 173-186
14. Clark C., Bryden A., Dawe R., Moseley H., Ferguson J., and Ibbotson S.H. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19 3 (2003) 134-141
15. Szeimies R.M., Hein R., Baumler W., Heine A., and Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 74 2 (1994) 117-119
16. Crosbie J., Winser K., and Collins P. Mapping the light field of the Waldmann PDT 1200 lamp: potential for wide-field low light irradiance aminolevulinic acid photodynamic therapy. Photochem Photobiol 76 2 (2002) 204-207
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 1-2 (1983) 55-63
18. Oberdanner C.B., Kiesslich T., Krammer B., and Plaetzer K. Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosis. Photochem Photobiol 76 6 (2002) 695-703
19. Plaetzer K., Kiesslich T., Oberdanner C.B., and Krammer B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr Pharm Des 11 9 (2005) 1151-1165
20. Plaetzer K., Kiesslich T., Verwanger T., and Krammer B. The modes of cell death induced by PDT: an overview. Med Laser Appl 18 1 (2003) 7-19
21. Plaetzer K., Kiesslich T., Krammer B., and Hammerl P. Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS4-PDT. Photochem Photobiol Sci 1 3 (2002) 172-177
22. Berlanda J., Kiesslich T., Oberdanner C.B., Obermair F.J., Krammer B., and Plaetzer K. Characterization of apoptosis induced by photodynamic treatment with hypericin in a431 human epidermoid carcinoma cells. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 173-188
23. Kiesslich T., Plaetzer K., Oberdanner C.B., Berlanda J., Obermair F.J., and Krammer B. Differential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction. FEBS Lett 579 1 (2005) 185-190
24. Oberdanner C.B., Plaetzer K., Kiesslich T., and Krammer B. Photodynamic treatment with fractionated light decreases production of reactive oxygen species and cytotoxicity in vitro via regeneration of glutathione. Photochem Photobiol 81 3 (2005) 609-613
25. Babilas P., Kohl E., Maisch T., Backer H., Gross B., Branzan A.L., et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 154 4 (2006) 712-718
26. Moseley H., Allen J.W., Ibbotson S., Lesar A., McNeill A., Camacho-Lopez M.A., et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol 154 4 (2006) 747-750
27. Edmund Industrial Optics. Product information on Brightline™ fluorescence filter sets. URL: 〈http://www.edmundoptics.com/onlinecatalog〉.
28. Linden S.M., and Neckers D.C. Type I and type II sensitizers based on Rose Bengal onium salts. Photochem Photobiol 47 4 (1988) 543-550